Supply Chain Traceability: Tıbbi Cihaz Yönetmeliği Art. 25, UDI Record Keeping (Art. 27) and ÜTS Individual Movement Notifications

SUMMARY
Supply chain traceability is regulated in Article 25 of the Tıbbi Cihaz Yönetmeliği (Medical Device Regulation): economic operators must be able to present to the Agency to whom they supplied a device and from whom they were supplied. Article 27 regulates the recording and retention of UDIs, and the Satış Reklam Tanıtım Yönetmeliği (Sales, Advertising and Promotion Regulation) regulates individual movement notification.
This article gives the provisions of Articles 24, 25 and 27, the record-keeping obligation of sales centers and the relevant provisions of the ÜTS Tekil Hareket Bildirimleri Kılavuzu (ÜTS Individual Movement Notifications Guide) as direct quotations.
Tıbbi cihazınızın ÜTS kaydı için: Tıbbi Cihaz ÜTS Kayıt Danışmanlığı
Contents
1. Free Movement: Art. 24
“(1) Unless otherwise stated in this Regulation, the making available on the market or putting into service of devices that meet the requirements of this Regulation shall not be refused, prohibited or restricted.”
The provision is for devices that meet the requirements of the Regulation and carries the qualification “unless otherwise stated in this Regulation”. For market surveillance measures, see our article on market surveillance and control.
2. Art. 25 (1): Cooperation of Distributor and Importer
“ARTICLE 25 -(1) Distributors and importers shall cooperate with manufacturers or authorized representatives to achieve an appropriate level of traceability of devices.”
The other obligations of distributors and importers are in our article on importer and distributor obligations.
3. Art. 25 (2): From Whom Received, To Whom Supplied
“(2) Economic operators shall be able to present the following to the Agency and, where the device is made available on the EU market, to the competent authorities of the relevant EU Member States, for the period referred to in the eighth paragraph of Article 10:”
“(a) any economic operator to whom they have directly supplied a device,”
“(b) any economic operator who has directly supplied them with a device,”
“(c) any health institution or healthcare professional to which they have directly supplied a device.”
The paragraph ends with the expression “sunabilmelidir” (must be able to present). There are three directions:
(a) The economic operators to which the device was directly supplied.
(b) The economic operators that directly supplied the device.
(c) The health institutions and healthcare professionals to which the device was directly supplied.
The definition of economic operator is in Article 3, subparagraph (ş):
“(ş) Economic operator: the manufacturer, the authorized representative, the importer, the distributor or the person referred to in paragraphs one and three of Article 22,”
4. Retention Period: Art. 10 (8)
Art. 25 (2) ties the period to the eighth paragraph of Article 10. Subparagraph (a) of that paragraph:
“(a) keep the technical documentation, the EU declaration of conformity and, if applicable, a copy of any relevant certificate issued in accordance with Article 56, including any amendments and supplements, available for a period of at least 10 years after the last device covered by the EU declaration of conformity has been placed on the market, and present them to the Agency upon request. For implantable devices, this period is at least 15 years after the last device has been placed on the market.”
Accordingly, the period is at least 10 years after the last device covered by the declaration of conformity is placed on the market, and at least 15 years for implantable devices.
5. UDI Recording and Retention: Art. 27
Art. 27 (1) lists one of the elements of the UDI system as follows:
“(c) the keeping of records of the UDI by economic operators, health institutions and healthcare professionals, in accordance with the conditions laid down in paragraphs eight and nine.”
“(8) Economic operators shall store and keep, preferably by electronic means, the UDI of the devices which they have supplied or with which they have been supplied, if those devices are class III implantable devices or devices, categories or groups of devices determined by the Commission.”
The ninth paragraph is for health institutions and healthcare professionals:
“(a) Health institutions shall store and keep, preferably by electronic means, the UDI of the devices with which they have been supplied, if those devices are class III implantable devices.”
“(b) For devices other than class III implantable devices, health institutions are encouraged to store and keep, preferably by electronic means, the UDI of the devices with which they have been supplied, and may be required to do so where necessary.”
“(c) Healthcare professionals are encouraged to store and keep, preferably by electronic means, the UDI of the devices with which they have been supplied, and may be required to do so where necessary.”
The concepts of UDI-DI and UDI-PI are in our article on UDI system, UDI-DI and Basic UDI-DI.
6. Sales Center’s Individual Movement and Record Obligation
Tıbbi Cihaz Satış, Reklam ve Tanıtım Yönetmeliği (Regulation on Medical Device Sales, Advertising and Promotion), Art. 8 (4):
“Sales centers are obliged to register the medical devices they place on the market or make available on the market in the record and information management system established by the Agency, to keep the registered information up to date, and to carry out individual movement notification transactions in order to ensure the traceability of these devices.”
Article 31 (3) of the same regulation:
“(3) Sales centers shall keep, in an orderly manner and on the basis of parameters such as batch, series, lot, brand and model, the records of the name, trade name or brand and contact details of the previous and, if any, the next economic operator in the supply chain, and other information that will facilitate the tracking of devices; they shall retain these records for at least ten years from the date they begin to make the device available on the market and shall submit them to the Agency upon request.”
The other paragraphs of Article 31 are in our article on sales center record keeping, alert system and ten-year record.
7. ÜTS Individual Movement Notifications
Scope of the TİTCK Tekil Hareket Bildirimlerine İlişkin Kılavuz (Guide on Individual Movement Notifications):
“Article 2- (1) This Guide contains the procedures and principles to be followed in carrying out the individual tracking, in the Product Tracking System (ÜTS), of products within the scope of the Medical Device Regulations, from the manufacture/import process until they reach the end user.”
“Article 5- (1) Medical devices are tracked by serial and/or lot number according to the production process determined by the manufacturer.”
Changes of hands in the chain are tracked with giving and receiving notifications:
“Article 9- (1) When individual products owned by an institution/firm/hospital are to be given to another institution/firm/hospital, a giving notification is made.”
“(2) If a receiving notification has not been made by the counterpart institution/firm/hospital in response to the giving notification, the stock transfer for that product does not take place.”
“(5) When making a giving notification, any information such as invoice no/waybill no/record that will facilitate the connection/tracking between the institution making the giving notification and its counterpart can be entered in the document number field, which is a mandatory field.”
There are separate notifications for sales outside the chain and for export: the “Tüketiciye Verme Bildirimi” (Giving to Consumer Notification) (Art. 14) for devices a sales center sells directly to a citizen, the “Tanımsız Yere Verme Bildirimi” (Giving to Undefined Place Notification) (Art. 16) for devices sold to a place that cannot be defined in ÜTS, and the “İhracat Bildirimi” (Export Notification) (Art. 17) for exported individual products. The details of the notification types are in our article on ÜTS individual movement notifications.
8. Individual Product Movement in a Withdrawal
“Article 18- (1) A withdrawal decision is made for a product whose use is found unsuitable by TİTCK or by the manufacturer/importer that placed the product on the market. The movement of individual products for which a withdrawal decision has been made, to the relevant institutions to be subjected to corrective action or not to be placed on the market again, is made only with the “Geri Çekme Verme Bildirimi” (Withdrawal Giving Notification).”
“(2) A giving notification cannot be used for individual products subject to a withdrawal decision.”
“(3) A new manufacture/import notification cannot be made for the lot number for which a withdrawal decision has been made.”
Under Art. 31 of the Guide, manufacturer and importer firms can track their individual products in the system:
“Article 31- (1) Manufacturer/importer firms can view their individual products that are in the system and that have left the system from the “Üretici/İthalatçı Tekil Ürün Sorgula” (Manufacturer/Importer Individual Product Query) menu.”
For ÜTS individual notification transactions, see our page on the ÜTS individual notification service.
9. Frequently Asked Questions
When are supply chain records presented to the Agency?
Art. 25 (2) says economic operators “must be able to present” this information to the Agency. For sales centers, Art. 31 (3) states that the records will be presented to the Agency upon request.
How long are traceability records kept?
Art. 25 (2) ties the period to Art. 10 (8): at least 10 years after the last device is placed on the market, and at least 15 years for implantable devices. For sales centers, Art. 31 (3) provides at least ten years from the date they begin to make the device available on the market.
Are devices sold directly to a health institution also recorded?
Yes. Art. 25 (2) (c) requires that every health institution or healthcare professional to which the device was directly supplied can be presented.
For which devices is UDI recording mandatory?
Under Art. 27 (8), economic operators store and keep, preferably by electronic means, the UDI of class III implantable devices and of devices determined by the Commission. For health institutions, the obligation covers class III implantable devices.
When does a product for which a giving notification has been made pass into the counterpart’s stock?
Under Art. 9 (2) of the Individual Movement Notifications Guide, the stock transfer does not take place unless the counterpart makes a receiving notification.
Tıbbi cihazınızın ÜTS kaydı için: Tıbbi Cihaz ÜTS Kayıt Danışmanlığı
Sources



